Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
54 巻, 10 号
選択された号の論文の29件中1~29を表示しています
ORIGINAL ARTICLES
  • Tomoyuki Nagao, Yasuya Inden, Masayuki Shimano, Masaya Fujita, Satoshi ...
    2015 年 54 巻 10 号 p. 1167-1173
    発行日: 2015年
    公開日: 2015/05/15
    ジャーナル オープンアクセス
    Objective Uninterrupted oral warfarin strategy has become the standard protocol to prevent complications during catheter ablation (CA) for the treatment of atrial fibrillation (AF). However, little is known about the safety and efficacy of uninterrupted dabigatran therapy in patients undergoing CA for AF. Therefore, this study investigated the safety and efficacy of uninterrupted dabigatran therapy and compared the findings with those for uninterrupted warfarin therapy.
    Methods Bleeding and thromboembolic events during the periprocedural period were evaluated in 363 consecutive patients who underwent CA for AF at Nagoya University Hospital, and received uninterrupted dabigatran (n=173) or uninterrupted warfarin (n=190) for periprocedural anticoagulation.
    Results A total of 27 (7%) patients experienced either bleeding or thromboembolic complications. Major bleeding complications occurred in 2 (1%) patients in the dabigatran group (DG) and 2 (1%) patients in the warfarin group (WG). Eight (5%) patients in the DG and 9 (5%) patients in the WG experienced groin hematoma, a type of minor bleeding complication. Meanwhile, no patient in the DG and 1 (1%) in the WG developed cerebral ischemic stroke. Overall, there was no significant difference between the groups for any category. The activated partial thromboplastin time (APTT) independently predicted periprocedural complications in the DG.
    Conclusion Uninterrupted dabigatran therapy in CA for AF thus may be a safe and effective anticoagulant therapy, and appears to be closely similar to continuous warfarin; however, it is essential to pay close attention to the APTT values when using dabigatran during CA.
  • Kenichi Iijima, Masaomi Chinushi, Osamu Saitoh, Kanae Hasegawa, Keiko ...
    2015 年 54 巻 10 号 p. 1175-1182
    発行日: 2015年
    公開日: 2015/05/15
    ジャーナル オープンアクセス
    Objective The dominant frequency (DF) in frequency analyses is considered to represent the objective cycle length and complexity of activation under conditions of ventricular fibrillation (VF). However, knowledge regarding the mechanisms determining the DF in human VF is limited. We studied the characteristics of the DF of human VF and relationship between DF and the defibrillation threshold.
    Methods Seventy-two implantable cardioverter-defibrillator patients and 211 VF were studied. Using defibrillation tests, we performed a frequency analysis with fast Fourier transformation. The correlations between DF and clinical characteristics, including the defibrillation threshold, were assessed.
    Results The mean DF of all induced VFs was 5.2±0.8 Hz. The patients were divided into two groups according to DF: the low-DF (DF <5.2 Hz, n=32) and high-DF (DF ≥5.2 Hz, n=40) groups. The frequency of structural heart disease was significantly higher in the low-DF group. In addition, the QRS duration, QT interval and effective refractory period of the right ventricle (RV-ERP) were significantly longer in the low-DF group. A multivariate analysis showed RV-ERP to be the only independent predictor of DF. Excluding patients receiving group III anti-arrhythmic drugs, which are known to have potent defibrillation threshold effects, the defibrillation threshold was significantly lower in the low-DF group (p=0.026).
    Conclusion We found that the DF of human VF is associated with underlying heart disease, the cardiac function, cardiac conduction, ventricular refractoriness and defibrillation threshold. Our findings may be useful for identifying and managing patients with a high defibrillation threshold.
  • Akiko Ishimatsu, Hiroshi Nakano, Hiroko Nogami, Makoto Yoshida, Tomoak ...
    2015 年 54 巻 10 号 p. 1183-1191
    発行日: 2015年
    公開日: 2015/05/15
    ジャーナル オープンアクセス
    Objective There is a discrepancy in the intensity of breath sounds in chronic obstructive pulmonary disease (COPD) patients between subjective studies, which have reported a diminished intensity, and objective studies using airflow-standardized measurements, which have not demonstrated a diminished intensity. We herein evaluated the breath sound intensity in COPD patients during tidal breathing in order to obtain clinically relevant results.
    Methods The subjects included 20 stable COPD patients and 20 normal controls. Microphones were attached to six sites on the chest wall, and breath sounds at the chest wall and airflow in the mouth were measured during resting tidal and deep tidal breathing. The octave-band power values of the breath sounds were subsequently calculated.
    Results 1. During resting breathing, the intensity of breath sounds during both inspiration and expiration was significantly greater in the COPD group than in the control group; the difference was prominent at higher frequency bands (>400 Hz). In addition, the power of the high frequency bands tended to be positively correlated with the CT visual emphysema scores but not the forced expiratory volume in one second, The airflow during resting breathing did not differ between the two groups. 2. During deep breathing, the intensity of inspiratory breath sounds at the dominant frequency band (200-400 Hz) was diminished over the upper and middle lung fields in the COPD group compared to that observed in the control group, while the intensity during expiration was not. The airflow during deep breathing was lower in the COPD group than in the control group.
    Conclusion In the present study, the breath sound intensity in the COPD patients was diminished during deep inspiration due to a reduced airflow and increased during both resting inspiration and expiration.
  • Tomomasa Tsuboi, Toru Oga, Kensuke Sumi, Kazuko Machida, Motoharu Ohi, ...
    2015 年 54 巻 10 号 p. 1193-1198
    発行日: 2015年
    公開日: 2015/05/15
    ジャーナル オープンアクセス
    Objective In subjects with chronic obstructive pulmonary disease (COPD), the effect of partial pressure of CO2 (PaCO2) alterations during long-term non-invasive ventilation (NIV) on continuance remains uncertain. We herein investigated the utility of PaCO2 stability during long-term NIV as a prognostic outcome.
    Methods We retrospectively assessed data from 54 subjects with COPD who received long-term NIV. The annual alteration in PaCO2 during NIV was determined using a simple linear regression method for each subject who had at least two 6-month intervals of PaCO2 data. Annual alterations in PaCO2 during long-term NIV and probable confounders were examined, and long-term NIV discontinuation was the major outcome.
    Results Data from 37 subjects who met the criteria were analyzed. PaCO2 during long-term NIV increased slightly in 19 subjects (group 1, <2 mm Hg/y), and increased greatly in 18 subjects (group 2, >2 mmHg/y). In the multivariate modality model, smaller annual alterations in PaCO2 (p=0.009) and lower PaCO2 6 months after the start of long-term NIV (6 m-PaCO2) (p=0.03) were associated with a significantly higher probability of continuing NIV. The 2- and 5-year probabilities of continuing NIV were 89% and 66% for group 1 and 78% and 32% for group 2, respectively.
    Conclusion A lower 6 m-PaCO2 and a lower annual alteration of PaCO2 during long-term NIV are significant predictive variables for patients with COPD.
  • Tomoko Saito, Satoko Ohfuji, Tsuyoshi Matsumura, Toshio Saito, Kazuhir ...
    2015 年 54 巻 10 号 p. 1199-1205
    発行日: 2015年
    公開日: 2015/05/15
    ジャーナル オープンアクセス
    Objective To examine the safety of and immune response to the influenza A(H1N1)pdm09 vaccine in patients with Duchenne muscular dystrophy (DMD).
    Methods Forty-four non-ambulatory patients with DMD hospitalized in a muscle disease ward and 41 healthy healthcare workers each received one dose of the influenza A(H1N1)pdm09 vaccine. Serum samples were collected before and four weeks after vaccination to measure the hemagglutinin inhibition antibody titers.
    Results No severe adverse events were noted in any of the subjects. The immune responses of the patients were comparable to those of the healthcare workers. Among the patients, tube feeding and a lower total protein level in the serum were identified to be significantly associated with a lower immune response.
    Conclusion A single dose of the vaccine was found to be safe and induced an optimal level of immunity in the DMD patients. The nutritional status may be associated with the immune response in patients with DMD.
CASE REPORTS
PICTURES IN CLINICAL MEDICINES
feedback
Top